318 related articles for article (PubMed ID: 31140101)
1. BATF2 reverses multidrug resistance of human gastric cancer cells by suppressing Wnt/β-catenin signaling.
Yang W; Wu B; Ma N; Wang Y; Guo J; Zhu J; Zhao S
In Vitro Cell Dev Biol Anim; 2019 Jun; 55(6):445-452. PubMed ID: 31140101
[TBL] [Abstract][Full Text] [Related]
2. BATF2 inhibits chemotherapy resistance by suppressing AP-1 in vincristine-resistant gastric cancer cells.
Yang W; Zhao S; Wu B; Xu J; Wu Z; Guo J; Zeng R
Cancer Chemother Pharmacol; 2019 Dec; 84(6):1279-1288. PubMed ID: 31549215
[TBL] [Abstract][Full Text] [Related]
3. AP-2α reverses vincristine-induced multidrug resistance of SGC7901 gastric cancer cells by inhibiting the Notch pathway.
Lian W; Zhang L; Yang L; Chen W
Apoptosis; 2017 Jul; 22(7):933-941. PubMed ID: 28439677
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Bevacizumab-induced Epithelial-Mesenchymal Transition by BATF2 Overexpression Involves the Suppression of Wnt/β-Catenin Signaling in Glioblastoma Cells.
Huang W; Zhang C; Cui M; Niu J; Ding W
Anticancer Res; 2017 Aug; 37(8):4285-4294. PubMed ID: 28739720
[TBL] [Abstract][Full Text] [Related]
5. miRNA-765 mediates multidrug resistance via targeting BATF2 in gastric cancer cells.
Lin W; Miao Y; Meng X; Huang Y; Zhao W; Ruan J
FEBS Open Bio; 2020 Jun; 10(6):1021-1030. PubMed ID: 32166887
[TBL] [Abstract][Full Text] [Related]
6. DJ-1 is involved in the multidrug resistance of SGC7901 gastric cancer cells through PTEN/PI3K/Akt/Nrf2 pathway.
Qiu L; Ma Z; Li X; Deng Y; Duan G; Zhao LE; Xu X; Xiao L; Liu H; Zhu Z; Chen H
Acta Biochim Biophys Sin (Shanghai); 2020 Dec; 52(11):1202-1214. PubMed ID: 33079995
[TBL] [Abstract][Full Text] [Related]
7. m
Xie JW; Huang XB; Chen QY; Ma YB; Zhao YJ; Liu LC; Wang JB; Lin JX; Lu J; Cao LL; Lin M; Tu RH; Zheng CH; Huang CM; Li P
Mol Cancer; 2020 Jul; 19(1):114. PubMed ID: 32650804
[TBL] [Abstract][Full Text] [Related]
8. Silence of FAM83H-AS1 promotes chemosensitivity of gastric cancer through Wnt/β-catenin signaling pathway.
Wang B; Guan G; Zhao D
Biomed Pharmacother; 2020 May; 125():109961. PubMed ID: 32028241
[TBL] [Abstract][Full Text] [Related]
9. miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells.
Xia L; Zhang D; Du R; Pan Y; Zhao L; Sun S; Hong L; Liu J; Fan D
Int J Cancer; 2008 Jul; 123(2):372-379. PubMed ID: 18449891
[TBL] [Abstract][Full Text] [Related]
10. Cardamonin, a natural chalcone, reduces 5-fluorouracil resistance of gastric cancer cells through targeting Wnt/β-catenin signal pathway.
Hou G; Yuan X; Li Y; Hou G; Liu X
Invest New Drugs; 2020 Apr; 38(2):329-339. PubMed ID: 31102118
[TBL] [Abstract][Full Text] [Related]
11. Regulation of drug resistance and metastasis of gastric cancer cells via the microRNA647-ANK2 axis.
Cao W; Wei W; Zhan Z; Xie D; Xie Y; Xiao Q
Int J Mol Med; 2018 Apr; 41(4):1958-1966. PubMed ID: 29328428
[TBL] [Abstract][Full Text] [Related]
12. Gastrin induces multidrug resistance via the degradation of p27Kip1 in the gastric carcinoma cell line SGC7901.
Zhuang K; Zhang L; Zhang X; Tang H; Zhang J; Yan Y; Han K; Guo H
Int J Oncol; 2017 Jun; 50(6):2091-2100. PubMed ID: 28498440
[TBL] [Abstract][Full Text] [Related]
13. miR‑1 reverses multidrug resistance in gastric cancer cells via downregulation of sorcin through promoting the accumulation of intracellular drugs and apoptosis of cells.
Deng LM; Tan T; Zhang TY; Xiao XF; Gu H
Int J Oncol; 2019 Aug; 55(2):451-461. PubMed ID: 31268161
[TBL] [Abstract][Full Text] [Related]
14. Shugoshin1 enhances multidrug resistance of gastric cancer cells by regulating MRP1, Bcl-2, and Bax genes.
Wang Y; Liu L; Liu X; Zhang H; Liu J; Feng B; Shang Y; Zhou L; Wu K; Nie Y; Zhang H; Fan D
Tumour Biol; 2013 Aug; 34(4):2205-14. PubMed ID: 23564482
[TBL] [Abstract][Full Text] [Related]
15. [Molecular mechanism of cisplatin to enhance the ability of TRAIL in reversing multidrug resistance in gastric cancer cells].
Zhu X; Zhang K; Wang Q; Chen S; Gou Y; Cui Y; Li Q
Zhonghua Zhong Liu Za Zhi; 2015 Jun; 37(6):404-11. PubMed ID: 26463141
[TBL] [Abstract][Full Text] [Related]
16. Proton pump inhibitor pantoprazole abrogates adriamycin-resistant gastric cancer cell invasiveness via suppression of Akt/GSK-β/β-catenin signaling and epithelial-mesenchymal transition.
Zhang B; Yang Y; Shi X; Liao W; Chen M; Cheng AS; Yan H; Fang C; Zhang S; Xu G; Shen S; Huang S; Chen G; Lv Y; Ling T; Zhang X; Wang L; Zhuge Y; Zou X
Cancer Lett; 2015 Jan; 356(2 Pt B):704-12. PubMed ID: 25449432
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of c-Myc by let-7b mimic reverses mutidrug resistance in gastric cancer cells.
Yang X; Cai H; Liang Y; Chen L; Wang X; Si R; Qu K; Jiang Z; Ma B; Miao C; Li J; Wang B; Gao P
Oncol Rep; 2015 Apr; 33(4):1723-30. PubMed ID: 25633261
[TBL] [Abstract][Full Text] [Related]
18. Identification of triosephosphate isomerase as an anti-drug resistance agent in human gastric cancer cells using functional proteomic analysis.
Wang X; Lu Y; Yang J; Shi Y; Lan M; Liu Z; Zhai H; Fan D
J Cancer Res Clin Oncol; 2008 Sep; 134(9):995-1003. PubMed ID: 18309519
[TBL] [Abstract][Full Text] [Related]
19. CIAPIN1 confers multidrug resistance by upregulating the expression of MDR-1 and MRP-1 in gastric cancer cells.
Hao Z; Li X; Qiao T; Du R; Hong L; Fan D
Cancer Biol Ther; 2006 Mar; 5(3):261-6. PubMed ID: 16410721
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of FOXS1 in gastric cancer cell lines inhibits proliferation, metastasis, and epithelial-mesenchymal transition of tumor through downregulating wnt/β-catenin pathway.
Lu Q; Ma X; Li Y; Song W; Zhang L; Shu Y; Wan B
J Cell Biochem; 2019 Mar; 120(3):2897-2907. PubMed ID: 30500980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
